Skip to main content

ADVERTISEMENT

cervical cancer

Research in Review
11/04/2016
JCP Editors
Though proven to offer superior outcomes versus other treatment regimens, less than half of patients receive standard of care for locally advanced cervical cancer, according to a study published in Gynecologic...
Though proven to offer superior outcomes versus other treatment regimens, less than half of patients receive standard of care for locally advanced cervical cancer, according to a study published in Gynecologic...
Though...
11/04/2016
Journal of Clinical Pathways
Research in Review
06/28/2016
JCP Editors
Cisplatin and paclitaxel may be the most cost-effective chemotherapy combination for women with advanced, persistent, or recurrent cervical cancer, according to research published in Dovepress. In the study,...
Cisplatin and paclitaxel may be the most cost-effective chemotherapy combination for women with advanced, persistent, or recurrent cervical cancer, according to research published in Dovepress. In the study,...
...
06/28/2016
Journal of Clinical Pathways
Research in Review
04/01/2016
JCP Editors
A model developed using data from health care databases and published literature has found that Pap plus human papillomavirus (HPV) mRNA testing that includes genotying for HPV 16 and 18 may be a more effective...
A model developed using data from health care databases and published literature has found that Pap plus human papillomavirus (HPV) mRNA testing that includes genotying for HPV 16 and 18 may be a more effective...
A...
04/01/2016
Journal of Clinical Pathways
03/30/2016
JCP Editors
Despite being at a greater risk for bone loss after prophylactic oophorectomy, carriers of BRCA mutations are under-screened for bone mineral density, according to a recent study. Women with BRCA1 or BRCA2 have a...
Despite being at a greater risk for bone loss after prophylactic oophorectomy, carriers of BRCA mutations are under-screened for bone mineral density, according to a recent study. Women with BRCA1 or BRCA2 have a...
...
03/30/2016
Journal of Clinical Pathways
Research in Review
01/28/2016
JCP Editors
Radical radiotherapy is more cost-effective for the treatment of cervical cancer than radical hysterectomy plus adjuvant radiotherapy, according to a recent study. National Comprehensive Cancer Network guidelines...
Radical radiotherapy is more cost-effective for the treatment of cervical cancer than radical hysterectomy plus adjuvant radiotherapy, according to a recent study. National Comprehensive Cancer Network guidelines...
...
01/28/2016
Journal of Clinical Pathways